Literature DB >> 16929349

Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease.

J R Bilbao1, B Calvo, A M Aransay, A Martin-Pagola, G Perez de Nanclares, T A Aly, I Rica, J C Vitoria, S Gaztambide, J Noble, P R Fain, Z L Awdeh, C A Alper, L Castaño.   

Abstract

The major susceptibility locus for type 1 diabetes mellitus (T1D) maps to the human lymphocyte antigen (HLA) class II region in the major histocompatibility complex on chromosome 6p21. In southern European populations, like the Basques, the greatest risk to T1D is associated with DR3 homo- and heterozygosity and is comparable to that of DR3/DR4, the highest risk genotype in northern European populations. Celiac disease (CD) is another DR3-associated autoimmune disorder showing certain overlap with T1D that has been explained by the involvement of common genetic determinants, a situation more frequent in DR3-rich populations, like the Basques. As both T1D- and CD-associated HLA alleles are part of conserved extended haplotypes (CEH), we compared DR3-homozygous T1D and CD patients to determine whether CEHs were equally distributed between both disorders or there was a differential contribution of different haplotypes. We observed a very pronounced distribution bias (P<10(-5)) of the two major DR3 CEHs, with DR3-B18 predominating in T1D and DR3-B8 in CD. Additionally, high-density single nucleotide polymorphism (SNP) analysis of the complete CEH [A*30-B*18-MICA*4-F1C30-DRB1*0301-DQB1*0201-DPB1*0202] revealed extraordinary conservation throughout the 4.9 Mbp analyzed supporting the existence of additional diabetogenic variants (other than HLA-DRB1*0301-DQB1*0201), conserved within the DR3-B18 CEH (but not in other DR3 haplotypes) that could explain its enhanced diabetogenicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16929349     DOI: 10.1038/sj.gene.6364328

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  15 in total

1.  Protective effect of HLA-DQB1 alleles against alloimmunization in patients with sickle cell disease.

Authors:  Zohreh Tatari-Calderone; Heather Gordish-Dressman; Ross Fasano; Michael Riggs; Catherine Fortier; Andrew D Campbell; Dominique Charron; Victor R Gordeuk; Naomi L C Luban; Stanislav Vukmanovic; Ryad Tamouza
Journal:  Hum Immunol       Date:  2015-10-22       Impact factor: 2.850

Review 2.  The past, present, and future of genetic associations in type 1 diabetes.

Authors:  Peter R Baker; Andrea K Steck
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

3.  The frequent and conserved DR3-B8-A1 extended haplotype confers less diabetes risk than other DR3 haplotypes.

Authors:  E E Baschal; T A Aly; J M Jasinski; A K Steck; K N Johnson; J A Noble; H A Erlich; G S Eisenbarth
Journal:  Diabetes Obes Metab       Date:  2009-02       Impact factor: 6.577

4.  Banting Lecture 2009: An unfinished journey: molecular pathogenesis to prevention of type 1A diabetes.

Authors:  George S Eisenbarth
Journal:  Diabetes       Date:  2010-04       Impact factor: 9.461

5.  Exploring the diabetogenicity of the HLA-B18-DR3 CEH: independent association with T1D genetic risk close to HLA-DOA.

Authors:  I Santin; A Castellanos-Rubio; A M Aransay; G Gutierrez; S Gaztambide; I Rica; J L Vicario; J A Noble; L Castaño; J R Bilbao
Journal:  Genes Immun       Date:  2009-05-21       Impact factor: 2.676

6.  Defining multiple common "completely" conserved major histocompatibility complex SNP haplotypes.

Authors:  Erin E Baschal; Theresa A Aly; Jean M Jasinski; Andrea K Steck; Janelle A Noble; Henry A Erlich; George S Eisenbarth
Journal:  Clin Immunol       Date:  2009-05-07       Impact factor: 3.969

7.  A stochastic epigenetic Mendelian oligogenic disease model for type 1 diabetes.

Authors:  Chester A Alper; Charles E Larsen; Michael R Trautwein; Dennis R Alford
Journal:  J Autoimmun       Date:  2018-10-08       Impact factor: 7.094

8.  HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families.

Authors:  Henry Erlich; Ana Maria Valdes; Janelle Noble; Joyce A Carlson; Mike Varney; Pat Concannon; Josyf C Mychaleckyj; John A Todd; Persia Bonella; Anna Lisa Fear; Eva Lavant; Anthony Louey; Priscilla Moonsamy
Journal:  Diabetes       Date:  2008-02-05       Impact factor: 9.461

9.  HLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type 1 diabetes: analysis of the type 1 diabetes genetics consortium families.

Authors:  Michael D Varney; Ana Maria Valdes; Joyce A Carlson; Janelle A Noble; Brian D Tait; Persia Bonella; Eva Lavant; Anna Lisa Fear; Anthony Louey; Priscilla Moonsamy; Josyf C Mychaleckyj; Henry Erlich
Journal:  Diabetes       Date:  2010-04-27       Impact factor: 9.461

10.  HLA and celiac disease susceptibility: new genetic factors bring open questions about the HLA influence and gene-dosage effects.

Authors:  Luz María Medrano; Bárbara Dema; Arturo López-Larios; Carlos Maluenda; Andrés Bodas; Natalia López-Palacios; M Ángeles Figueredo; Miguel Fernández-Arquero; Concepción Núñez
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.